AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Byline: Judy Peres
CHICAGO _ A drug already approved for osteoporosis could significantly reduce the number of women getting breast cancer, government-sponsored researchers announced Monday.
The drug, raloxifene, lowers the risk of breast cancer in postmenopausal women as effectively as tamoxifen but with fewer side effects. Doctors said that could encourage many more healthy women to take it to prevent the feared disease.
"Patients have already started calling in," said Dr. Kathy Albain, director of the breast research program at Loyola University Medical Center.
Although tamoxifen was approved for breast cancer prevention in 1998, only a fraction of the women who are eligible to take it actually do so. The drug is used mainly to treat breast cancer, rather than to prevent it.
Doctors say women who don't already have the disease are afraid of tamoxifen's serious side effects _…
Source: HighBeam Research, Bone drug lowers risk of breast cancer, study finds.